MoneyWorks4Me

Piramal Pharma gets EIR from USFDA for Telangana manufacturing facility

18 May 2026 Evaluate

Piramal Pharma has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (USFDA) for its manufacturing facility located at Digwal, Telangana, India. The receipt of said EIR marks successful closure of the inspection.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. 


Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1224.80
Cipla 1385.65
Lupin 2069.50
Zydus Lifesciences 1217.50
View more..